Back to everyone

Alex Hammacher

Head of Strategic Operations & Corporate Finance

Alex Hammacher

Alex joined Oxford Science Enterprises in October 2019, bringing over two decades of clinical medicine and corporate finance experience.

Alex is responsible for major corporate finance activities at OSE and its later stage companies, including public market transactions, acquisitions and exits. He also manages OSE’s Investment Committee, and leads long-term strategic planning.

Alex began his career as a junior doctor in Oxford before joining investment banking in 2007. He has raised equity and debt capital for both private and public companies, and advised on local and cross-border M&A and partnerships whilst at UBS and Lazard in Europe, US and Australia-Pacific. His experience includes both large cap pharma and medtech, early-stage biotech and digital health, as well as cleantech, utilities and infrastructure.

Alex holds degrees in medicine & surgery and physiological sciences from the University of Oxford.

Alex sits on the board of

  • Barinthus Biotherapeutics
  • Evolito
  • Evox Therapeutics

Meet all our


Athene Blakeman
Athene BlakemanHead of Legal
Claire LaRocca
Claire LaRoccaHead of Communications
Emily Matthews
Emily MatthewsResponsible Investment & ESG Manager
Jim Wilkinson
Jim WilkinsonChief Financial Officer
Jon Wall
Jon WallPortfolio Tech Talent Lead
Lilly Bussmann
Lilly BussmannHead of Strategic Capital
Lisa Bedwell
Lisa BedwellHead of Marketing
Matthew Myers
Matthew MyersAssociate
Nick Dixon-Clegg
Nick Dixon-CleggPartner, Head of Independent Investments
Oliver Mahony
Oliver MahonyPrincipal
Pete Wilder
Pete WilderHead of Property
Polly Elvin
Polly ElvinHead of Investor Relations & Co-Investors
Sarah Shackelton
Sarah ShackeltonChief Talent Officer
Sive Ozer
Sive OzerSenior Legal Counsel
Wallace Wallace
Wallace WallaceAssociate